In yesterday’s Wall Street session, HCA Healthcare Inc. (NYSE:HCA) shares traded at $248.88, up 2.33% from the previous session.
25 analysts cover HCA Healthcare Inc. (NYSE:HCA), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $308.00 and a low of $150.00, we find $244.50. Given the previous closing price of $243.21, this indicates a potential upside of 0.53 percent. HCA stock price is now 8.14% away from the 50-day moving average and 15.70% away from the 200-day moving average. The market capitalization of the company currently stands at $70.49B.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
The stock has received a hold rating from 5 analysts and a buy rating from 17. Brokers who have rated the stock have averaged $251.32 as their price target over the next twelve months.
With the price target reduced from $233 to $160, BMO Capital Markets Downgraded its rating from Market Perform to Underperform for HCA Healthcare Inc. (NYSE: HCA). On June 17, 2022, Loop Capital recently initiated its ‘Buy’ rating on the stock quoting a target price of $240, while ‘Bernstein’ rates the stock as ‘Outperform’.
In other news, MOORE A BRUCE JR, Group President – Service Line sold 10,000 shares of the company’s stock on Nov 11. The stock was sold for $2,240,690 at an average price of $224.07. Upon completion of the transaction, the Group President – Service Line now directly owns 30,807 shares in the company, valued at $7.67 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Oct 28, Group President Hall Charles J sold 9,838 shares of the business’s stock. A total of $2,198,793 was realized by selling the stock at an average price of $223.50. This leaves the insider owning 199,883 shares of the company worth $49.75 million. Insiders disposed of 279,117 shares of company stock worth roughly $69.47 million over the past 1 year. A total of 0.10% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in HCA stock. A new stake in HCA Healthcare Inc. shares was purchased by WOODLINE PARTNERS LP during the first quarter worth $81,263,000. HOLOCENE ADVISORS, LP invested $54,833,000 in shares of HCA during the first quarter. In the first quarter, ALYESKA INVESTMENT GROUP, L.P. acquired a new stake in HCA Healthcare Inc. valued at approximately $50,871,000. GREAT WEST LIFE ASSURANCE CO /CAN/ acquired a new stake in HCA for approximately $49,891,000. JUNTO CAPITAL MANAGEMENT LP purchased a new stake in HCA valued at around $45,541,000 in the second quarter. In total, there are 1,246 active investors with 66.80% ownership of the company’s stock.
On Wednesday morning HCA Healthcare Inc. (NYSE: HCA) stock kicked off with the opening price of $244.53. During the past 12 months, HCA Healthcare Inc. has had a low of $164.47 and a high of $279.02. The fifty day moving average price for HCA is $230.15 and a two-hundred day moving average price translates $215.10 for the stock.
The latest earnings results from HCA Healthcare Inc. (NYSE: HCA) was released for Sep, 2022. According to the Medical Care Facilities Company, earnings per share came in at $3.93, beating analysts’ expectations of $3.88 by 0.05. This compares to $7.63 EPS in the same period last year. The net profit margin was 9.00% and return on equity was -214.70% for HCA. The company reported revenue of $14.97 billion for the quarter, compared to $15.28 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -2.0 percent. For the current quarter, analysts expect HCA to generate $15.59B in revenue.
Moreover, the firm recently paid out its quarterly dividend on 12/28/2022. Investors who held shares on 12/14/2022 were paid a $0.56 dividend. On an annualized basis, this represents a $2.24 dividend and a 0.90% percent yield. There was an ex-dividend date of 12/13/2022 for this dividend. In terms of dividend payout ratio, HCA is presently at 12.00%.
HCA Healthcare Inc.(HCA) Company Profile
HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
